110 patients with severe refractory epilepsy, who previously had not perceived any beneficial effects from at least three different AEDs, fulfilled the study inclusion and exclusion criteria.

Epilepsy surgery has been shown to be an effective treatment for patients with intractable epilepsy. The only randomized controlled trial conducted in this setting to date found a dramatic ...

PERTH, Australia, Feb. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope to epilepsy patients. For thousands of patients with ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

With continued execution in the fourth quarter, Rapport is well positioned to deliver on multiple meaningful development milestones. The ...